Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. - Wikidata - wikimedia - TriplyDB

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

http://www.wikidata.org/entity/Q53189779

about

Follicular lymphoma: 2012 update on diagnosis and management Anthracycline-containing regimens for treatment of follicular lymphoma in adults Anthracyclines-containing regimens for treatment of follicular lymphoma in adults Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup Follicular lymphoma: 2011 update on diagnosis and management Functional genomics lead to new therapies in follicular lymphoma Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma Follicular lymphoma: 2014 update on diagnosis and management The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How Inherited genetic variation and overall survival following follicular lymphoma.Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma.Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Clinical significance of sIL-2R levels in B-cell lymphomas.Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas.Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy.Risk Factors of Follicular Lymphoma.Follicular lymphoma - treatment and prognostic factors.Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience.Therapy of newly diagnosed follicular lymphoma.Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India Considerations in the initial management of follicular lymphoma.Management of indolent lymphoma: where are we now and where are we going.

P2860

Q22252956-5C1C8BA7-FC18-45D7-9357-CDAF38AF6A36 Q24201306-D72B31D0-E101-4245-BDA7-0E5FB8EA5FB0 Q24236087-C38FCFF8-456B-4182-9692-496AC04DE001 Q26773194-B6314C48-0345-48A4-849C-1681AB1480F1 Q26851450-ECDD7F96-9ACF-4C92-B709-FBAF6E03A7E1 Q26852415-57D4E5F6-D3B6-4EBC-AA8F-31907292A41A Q27000310-D93CBF37-508A-4528-B1E0-8A83826BD3F5 Q27021850-F4C03DFF-75B6-415D-AE26-33841641A600 Q28072397-AC00C1A7-953B-4D2B-9BB1-052B2350F9E2 Q28073262-04723D6A-BF44-4DA7-BB2E-D880E3B1A77F Q30519549-346CDDFA-4C8D-49BD-A91F-C927BD19A5E3 Q33403958-B4915900-55DB-4C1E-B189-922D005F0D9C Q33415469-620FAA0E-1843-40BB-8700-DA8AD55BF1C9 Q33574197-0172DCC8-3CA1-43BC-A64F-35C91EFAAE3E Q33642244-247A1CF1-95F4-4736-B854-7776F7B4A699 Q33664022-68DFE7EF-D110-48EE-B7E0-F60C7CB448DF Q33800997-49235BA7-C197-4CFF-B305-503AC2DB99E7 Q33922745-EC0D527A-5C3E-44A6-AEC2-5B36985AA965 Q33931720-7531BA4C-19AA-4290-BB60-BAE9FD9398E6 Q34093532-E3FCC38A-1FA4-4A08-B3E7-FFEFABF5D376 Q34248556-4344A3F1-1926-4840-AAAC-DE009E45E8A3 Q34391446-51DDFE57-290A-49D9-9238-BBFA30D76793 Q34454573-555B8BFD-A357-4858-B9C5-EE380A1D57CE Q34525054-66420334-9945-47AB-9C47-54C399BD2067 Q34607801-EF148A82-5417-420C-947B-D4CEB63EA97C Q34663865-A590A286-DCCB-423F-9D62-B73042B78EDB Q35043560-785D765F-1E9E-4A32-B9A9-C47883475C23 Q35052000-29DD599C-265F-4C8F-8ECC-0059D9F78F58 Q35178103-5E4FBB2A-E5F8-4B78-A1E3-94D9B94AD5D8 Q35674557-210B7EBA-AB2D-487C-B91F-8C7FA00BF2A4 Q36062546-817CC216-E031-4D14-99F7-1B6977B7B5E5 Q36283823-D9A3B071-07F6-4827-96C6-C57F71E34168 Q36372975-0F3DEC6D-168F-4DCE-A4B2-44547C8C9BF1 Q36400279-841C3445-1350-4819-A942-CDB77830655C Q36429831-68F7DF4B-7933-410D-945E-371AE265B190 Q36448074-9C72AD15-21A4-4136-9C81-CC99F8998F85 Q36457298-1FA27F4B-8144-4FA8-94E0-3C4EF32F0FF4 Q36679573-9CD359D2-0EE9-47DD-9B81-901F5A7B2DF4 Q36724776-D4E96E19-5BC2-4C79-8C25-F4A5FEC0FDEF Q36784860-A7F7A7AC-4F20-4DE3-AF92-53D810908B31

P2860

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

http://www.wikidata.org/entity/Q53189779

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Follicular lymphoma internatio ...... oma prognostic factor project.

@en

Follicular lymphoma internatio ...... oma prognostic factor project.

@nl

type

label

Follicular lymphoma internatio ...... oma prognostic factor project.

@en

Follicular lymphoma internatio ...... oma prognostic factor project.

@nl

prefLabel

Follicular lymphoma internatio ...... oma prognostic factor project.

@en

Follicular lymphoma internatio ...... oma prognostic factor project.

@nl

P1433

Q53189779-0D4BA46B-C160-4172-B8FC-71A1A794BEEE

P1476

Q53189779-074AC56D-5BBD-4390-A569-7E9CA6A29C28

P2093

Q53189779-2639CB5A-04B8-4631-96D6-82F9437F122D

Q53189779-281F2078-BB9A-4863-9F20-1CFDAB21186F

Q53189779-2CD18E99-30E1-4C65-9B57-CBF4E083E7BE

Q53189779-2FAA95FD-9256-4D92-88B9-FB9EC046516E

Q53189779-4EE81942-0E02-4FC3-B6F8-F9531E83A9FD

Q53189779-6B2AFDD2-A203-41DD-B36B-805A319B4573

Q53189779-7A9B5D62-07EC-42A7-9F49-A87B0C1ED4B7

Q53189779-8A1B618A-7C2F-4127-BF01-4351ECC370B0

Q53189779-93E6BB40-0276-400C-8039-EC43D219BBD7

Q53189779-A030B252-8B9B-47C2-BBD7-F83E38A213E8

P304

Q53189779-87A18601-349E-4559-BF4E-CB375E43680B

P31

Q53189779-9763812F-BD87-4903-91D2-F1E4A5056760

P356

Q53189779-0ADF8848-897E-477A-B6F3-6CC0A7602AE7

P407

Q53189779-AC383114-B22D-41A4-A3AA-044A0040B062

P433

Q53189779-33AFB6E5-879D-48E9-8F1F-9BA04CB980AD

P478

Q53189779-071E7112-23F6-4225-94B9-A08E5B90A468

P50

Q53189779-204C1304-E650-4AF5-A28B-A33E4EC65502

Q53189779-66E6AB68-5B8F-413E-81E0-CDAC8E7DCD00

Q53189779-683462D2-B4FB-4E5D-9F71-0535CA6399AA

Q53189779-8259E9A8-4477-42B7-996F-EF86E962CC68

Q53189779-A174C545-BCA4-487A-8EAB-D62FBC1B0028

Q53189779-A1EBCA02-5FD4-45BA-90A8-C3A2E83D1C95

Q53189779-D4D76D71-BD10-4452-B280-042B3BCA1A71

Q53189779-D9463B4F-C7B8-4AD0-BED3-3A16196BB484

P577

Q53189779-F65B5452-F049-4340-9C8E-F499DE260CC6

P698

Q53189779-CB2880AD-3EBF-47DB-9BA1-EF71C5C53DBE

P356

JCO.2008.21.3991

P1433

Journal of Clinical Oncology

P1476

Follicular lymphoma internatio ...... homa prognostic factor project

@en

P2093

Alessandro Pulsoni

http://www.w3.org/2001/XMLSchema#string

Armando Lopez-Guillermo

http://www.w3.org/2001/XMLSchema#string

Barbara Pro

http://www.w3.org/2001/XMLSchema#string

Elena Sabattini

http://www.w3.org/2001/XMLSchema#string

Giovanni Martinelli

http://www.w3.org/2001/XMLSchema#string

Luigi Marcheselli

http://www.w3.org/2001/XMLSchema#string

Luigi Rigacci

http://www.w3.org/2001/XMLSchema#string

Maurizio Martelli

http://www.w3.org/2001/XMLSchema#string

Monica Bellei

http://www.w3.org/2001/XMLSchema#string

Peter McLaughlin

http://www.w3.org/2001/XMLSchema#string

P304

4555-4562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.21.3991

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Di Raimondo

Francesco Merli

Stefano Luminari

Massimo Federico

Massimo Federico

Pierre-Louis Soubeyran

P577

2009-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19652063

http://www.w3.org/2001/XMLSchema#string